Who Benefits from These Energy Enhancing Injections
Read our Privacy Policy and Terms of Service for more details
BPC-157 + TB-500 + GHK-Cu + KPV
TB-500 (and full T4) has a more developed preclinical cardiac evidence base than BPC-157, particularly in post-myocardial-infarction remodelling models, supported in part by NIH-funded investigation
Primary applications: wound healing (closure kinetics, collagen organization, tensile strength), tendon and ligament regeneration (Achilles transection, biomechanical testing), gastroprotection (NSAID protection, mucosal barrier, fistula healing), angiogenesis (HUVEC tube formation, VEGF expression, CAM assays), neuroprotection (gut-brain axis, neuroinflammatory reduction), and inflammation studies (cytokine modulation, ERK1/2 pathway)